NCT05700656View on ClinicalTrials.gov

Galunisertib Combined With Capecitabine in Advanced CRC With PM

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

July 28, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Colorectal Cancer MetastaticPeritoneal Carcinomatosis
Interventions
DRUG

Galunisertib plus capecitabine

Combination therapy with galunisertib plus capecitabine

Trial Locations (2)

1066CX

RECRUITING

Netherlands Cancer Institute, Amsterdam

1081 HV

NOT_YET_RECRUITING

Amsterdam UMC, Amsterdam

All Listed Sponsors
collaborator

Amsterdam UMC

OTHER

lead

The Netherlands Cancer Institute

OTHER